CONDENSED PYRIMIDINE COMPOUND OR SALT THEREOF Russian patent published in 2020 - IPC C07D487/04 A61K31/519 A61P35/00 

Abstract RU 2729636 C2

FIELD: medicine; pharmaceuticals.

SUBSTANCE: invention relates to a method for inhibiting RET, comprising administering to a patient a compound represented by formula (I)

,

where A is pyrazolyl, substituted with n-number of substitutes R1; R1 is halogen, cyano, C1-C6 alkyl, unsubstituted or substituted with at least one substitute selected from a group consisting of halogen and C1-C6 alkoxy, C3-C7 cycloalkyl, unsubstituted or substituted with at least one substitute selected from a group consisting of C1-C6 alkyl and halogen, C6 aromatic hydrocarbon substituted with at least one substitute selected from a group consisting of C1-C6 alkyl and halogen; or C4 monocyclic unsaturated heterocyclic group containing 1 heteroatom selected from oxygen and sulfur, which is unsubstituted or substituted with at least one substitute selected from a group consisting of C1-C6 alkyl and halogen; R2 is C1-C10 alkyl unsubstituted or substituted with at least one substitute selected from a group consisting of halogen, C1-C6 alkoxy, C3-C7 cycloalkyl, which can be substituted with C1-C4 alkyl, phenyl, one C4 monocyclic unsaturated heterocyclic group containing 1 heteroatom selected from oxygen and sulfur, C3-C7 cycloalkyl, unsubstituted or substituted with at least one substituent 1–2 times, selected from a group consisting of C1-C6 alkyl, halogen, C1-C6 haloalkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, unsubstituted or substituted with halogen, C4-C12 bonded cycloalkyl, unsubstituted or substituted 1–3 times with C1-C6 alkyl or C3-C10 monocyclic or bicyclic saturated or unsaturated heterocyclic group, containing 1–3 identical or different heteroatoms selected from nitrogen, oxygen and sulfur, which is unsubstituted or substituted with C1-C6 alkyl; X is N or CR3, where R3 is hydrogen, halogen, cyano, C1-C6 alkyl, unsubstituted or substituted C1-C6 alkoxy, C2-C6 alkynyl substituted with at least one substitute selected from a group consisting of C1-C6 alkyl, which can be substituted with hydroxy, C1-C6 alkoxy, pyridinyl, C3-C6 cycloalkyl, which can be substituted with hydroxy, N-C1-C6 alkylpyrazolyl, N-C1-C6 alkyl imidazolyl, morpholinyl, tetrahydropyranyl and imidazo(1,2-b)pyridazinyl, C1-C6 alkoxy, unsubstituted or substituted with tetrahydrofuran, n is an integer ranging from 0 to 3.

EFFECT: disclosed are a condensed pyrimidine compound or salt thereof.

36 cl, 4 dwg, 19 tbl, 90 ex

Similar patents RU2729636C2

Title Year Author Number
NEW CONDENSED PYRIMIDINE COMPOUND OR SALT THEREOF 2017
  • Miyazaki, Isao
  • Shimamura, Tadashi
  • Kato, Masanori
  • Fujita, Hidenori
  • Iguchi, Satoru
RU2770727C2
N-(4-(AZAINDAZOL-6-IL)-PHENYL)-SULFONAMIDES AND THEIR USE AS DRUGS 2014
  • Nazare Mark
  • Khallann Nis
  • Shmidt Fridemann
  • Kleemann Khajnts-Verner
  • Vajss Tilo
  • Zaas Joakhim
  • Shtryubing Karsten
RU2671864C2
AMINO-SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND USE THEREOF AS PHARMACEUTICAL AGENTS 2012
  • Ruf Sven
  • Sadovski Torsten
  • Khorstik Georg
  • Shrojder Kherman
  • Buning Kristian
  • Olpp Tomas
  • Virt Klaus
RU2605600C2
SUBSTITUTED CHROMAN-6-YLOXY-CYCLOALKANES AND USE THEREOF AS MEDICAMENTS 2014
  • Chekhtitskij Verngard
  • Ueston Dzhon
  • Rakelmann Nils
  • Kraft Folker
  • Arndt Petra
  • Virt Klaus
  • Gegelyajn Khajnts
  • Rittseler Olaf
RU2666350C2
7H-PYRROLO[2,3-D]PYRIMIDINE-4-AMINE DERIVATIVE 2020
  • Yamamoto, Fuyuki
  • Mizutani, Takashi
  • Kasuga, Hidefumi
  • Fuchida, Hirokazu
  • Hara, Shoki
  • Kobayakawa, Yu
  • Ogino, Yoshio
RU2796605C2
DERIVATIVES OF HYDROXYMETHYLFURAZAN CARBOXYLIC ACID AND PHARMACEUTICAL PREPARATION 1994
  • Karl Shenafinger
  • Gel'Mut Bon
RU2134687C1
PYRAZOLPYRIMIDINE COMPOUNDS JAK INHIBITORS AND METHODS 2009
  • Blehjni Dzheffri
  • Gibbons Pol A.
  • Khanan Ehmili
  • Lissikatos Dzhozef P.
  • Magnuson Stiven R.
  • Pastor Richard
  • Rouson Tomas E.
  • Chzhou Ajkheh
  • Chzhu Bin-Jan'
RU2539568C2
FUSED PYRROLEDICARBOXAMIDES AND THEIR USE AS PHARMACEUTICALS 2013
  • Biali Loran
  • Lorents Katrin
  • Virt Klaus
  • Shtajnmejer Klaus
  • Khessler Gerkhard
RU2650111C2
PYRAZOLE DERIVATIVES AND THEIR USE AS LPAR5 ANTAGONISTS 2013
  • Nazare Mark
  • Kotsian Detlef
  • Efers Andreas
  • Chekhtizkij Verngard
RU2645344C2
ANTITUMOR EFFECT STRENGTHENING AGENT USING PYRAZOLO[3,4-d]PYRIMIDINE COMPOUND 2018
  • Irie, Hiroki
  • Oguchi, Kei
  • Fujioka, Yayoi
RU2799006C2

RU 2 729 636 C2

Authors

Miyazaki, Isao

Shimamura, Tadashi

Kato, Masanori

Fujita, Hidenori

Dates

2020-08-11Published

2016-09-07Filed